healthcare
UK Health Officials Say Patient's Death Partially Down to Cyberattack
Novo Nordisk Says WeightWatchers Will Sell Wegovy, Announces $299 Price
TechnologyBreaking Down the Business Case for Custom Healthcare Software Solutions in the Post-COVID Era
Novo Nordisk Launches Weight-Loss Drug Wegovy in India to Compete With Lilly's Mounjaro
US Approves AstraZeneca, Daiichi's Treatment for Lung Cancer
Date: June 24, 2025
(Reuters) -AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat a type of lung cancer, marking the first approval of the therapy...
Novo, Hims & Hers Engage in War of Words After Wegovy Deal Falls Apart
Date: June 23, 2025
COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs. The two companies had announced a collaboration in April...
Novo Nordisk Shares Fall as Obesity Pipeline Faces Investor Scrutiny
Date: June 23, 2025
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its experimental obesity drug CagriSema fuelled...
Data on Novo Nordisk Experimental Weight-Loss Drug Show Mostly Mild Side Effects
Date: June 22, 2025
By Deena Beasley (Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and...
Muscle-Preserving Drugs Could Generate Over $30 Billion in Sales by 2035, Td Cowen Says
Date: June 20, 2025
By Bhanvi Satija (Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in...
Trump Aid Cuts Deal a Blow to Hiv Prevention in Africa
Date: June 20, 2025
By Robbie Corey-Boulet (Reuters) -Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's administration cut access for at-risk groups...